Skip to main content
Premium Trial:

Request an Annual Quote

Agilent and Integrated Diagnostics Partner on Protein Biomarker Assays

NEW YORK (GenomeWeb News) – Agilent Technologies said today that it has partnered with Integrated Diagnostics to develop multiplexed protein biomarker-based assays for detecting diseases in their early stages.

The firms plan to develop high-throughput automated workflows for sample preparation and liquid chromatography mass spectrometry analysis, with the goal of accelerating biomarker discoveries by enabling screening of several hundred biomarkers in a single assay.

Under the collaboration, Integrated Diagnostics bought two Agilent 1290 Infinity UHPLC systems, two 6490 iFunnel triple quadrupole mass spectrometry systems, and two 1260 liquid chromatographers with ultraviolet detectors that it will use in the project.

"Integrated Diagnostics will bring expertise in assay development, technology strategy, study design, clinical development, commercialization and systems informatics to leverage the Agilent technology solution," Paul Kearney, president and chief scientific officer of Integrated Diagnostics, said in a statement.

He added that the partnership with Agilent "will allow us to realize the advantages of using a single technology platform from discovery and verification through to commercialization."

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.